GET A FULL VIEW OF THE COATING SPECTRUM WITH SOMEONE WHO CAN SEE ALL THE OPTIONS.

There are dozens of coating possibilities out there for your device, and it can be difficult to find one that performs optimally according to your unique specifications. At Formacoat, we aren't limited to one outfit — our wardrobe of coating contains nearly a hundred different varieties that come from fifty different vendors. We know how to tailor your coating needs, device expectations, and wildest dreams. Since we don't sell coatings, we see each option without bias, and can help select, tweak, and perfect each coating to fit your device with exacting precision. And then build a system that can do it again and again, up to full-scale production.


Our dedicated teams of chemists and engineers have experience with a stunning amount of coating varieties and a knack for effectively and efficiently visualizing coating solutions that fit all your needs. Now with two facilities of over 85,000 square feet of space devoted to commercial scale contract coating operations and powerful R&D, we are capable of more than ever before. With over 23 years of experience, Formacoat is ready to move your device coating selection from monotone to multichromatic.

Making the Tools of Medicine Run Smoother®
Call or Email Formacoat Today: (952) 895 0200  • Info@formacoat.com

Creatively Coating What You Dare to Dream
www.formacoat.com/dream

© 2024 Formacoat. All rights reserved.

Go to article: Home | Remote patient monitoring across chronic conditionsGo to article: Editor's letterGo to article: ContentsGo to article: Bellridge Company InsightGo to article: BriefingGo to article: News in NumbersGo to article: Latest NewsGo to article: Latest DealsGo to article: Project UpdatesGo to article: Alleima Company InsightGo to article: AlleimaGo to article: In DepthGo to article: Remote patient monitoring across chronic conditions Go to article: IVF: AI ushers new paradigm for fertility medicine Go to article: Family offices branching out to become ideal source for early MedTech funding Go to article: Explainer: Why paediatric healthcare is furious with the FDA’s LDT final ruling Go to article: A thorn in TGA’s side – spinal cord stimulators under fire in Australia Go to article: Repsol Company InsightGo to article: Repsol Go to article: Sponsored supplementsGo to article: ListingsGo to article: EventsGo to article: Excellence AwardsGo to article: Innovation RankingsGo to article: Buyer's GuidesGo to article: Formacoat Company InsightGo to article: FormacoatGo to article: Next issue